Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Imaging Technique Can Quantitatively Measure Cell Mass with Light

By BiotechDaily International staff writers
Posted on 08 Sep 2011
Researchers are providing new clues into the weighty question of cell growth.

Led by electrical and computer engineering professor Dr. Gabriel Popescu, from the University of Illinois (Urbana-Champaign, USA), the investigators developed a new imaging technique called spatial light interference microscopy (SLIM) that can measure cell mass using two beams of light. Published ahead of print July 25, 2011, in the Proceedings of the [US] National Academy of Science, the SLIM technique offers new clues into the much-debated question of whether cells grow at a constant rate or exponentially.

SLIM is extremely sensitive, quantitatively measuring mass with femtogram accuracy. By comparison, a micrometer-sized droplet of water weighs 1,000 femtograms. It can measure the growth of a single cell, and even mass transport within the cell. Yet, the technique is broadly applicable. “A significant advantage over existing methods is that we can measure all types of cells--bacteria, mammalian cells, adherent cells, nonadherent cells, single cells, and populations,” said Mustafa Mir, a graduate student and a first author of the article. “And all this while maintaining the sensitivity and the quantitative information that we get.”

Unlike most other cell-imaging techniques, SLIM--a combination of phase-contrast microscopy and holography--does not need staining or any other special preparation. Because it is completely noninvasive, the researchers can study cells as they go about their natural functions. It uses white light and it can be combined with more traditional microscopy techniques, such as fluorescence, to monitor cells as they grow. “We were able to combine more traditional methods with our method because this is just an add-on module to a commercial microscope,” Mr. Mir said. “Biologists can use all their old tricks and just add our module on top.”

Because of SLIM’s sensitivity, the scientists could monitor cells’ growth through different phases of the cell cycle. They discovered that mammalian cells show clear exponential growth only during the G2 phase of the cell cycle, after the DNA replicates and before the cell divides. This information has great implications not only for essential biology, but also for diagnostics, drug development, and tissue engineering.

The researchers hope to apply their new knowledge of cell growth to different disease models. For example, they plan to use SLIM to see how growth varies between normal cells and cancer cells, and the effects of treatments on the growth rate.

Dr. Popescu, a member of the Beckman Institute for Advanced Science and Technology at the University of Illinois, is establishing SLIM as a shared resource on the Illinois campus, hoping to exploit its flexibility for basic and clinical research in a number of areas. “It could be used in many applications in both life sciences and materials science,” stated Dr. Popescu, who also is a professor of physics and of bioengineering. “The interferometric information can translate to the topography of silicon wafers or semiconductors. It’s like an iPad--we have the hardware, and there are a number of different applications dedicated to specific problems of interest to different labs.”

Related Links:

University of Illinois





WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Exosomes loaded with catalase (shown in red) efficiently interact with neurons (shown in black) to protect them from the effects of Parkinson\'s disease (Photo courtesy of Dr. Elena Batrakova, University of North Carolina).

Exome Delivery of the Anti-Oxidant Catalase Reduces Parkinson's Disease Symptoms in Mouse Model

The exosome delivery of the antioxidant enzyme catalase was shown to dramatically reduce symptoms of Parkinson's disease (PD) in a mouse model. Exosomes are cell-derived vesicles that are present in... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

27 May 2015 - 28 May 2015
02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.